Evidence map›Paper›PMID 31440523›Full record

ArticleMolecular therapy. Methods & clinical development2019

Real-Time Monitoring of Exosome Enveloped-AAV Spreading by Endomicroscopy Approach: A New Tool for Gene Delivery in the Brain.

Nicola Salvatore Orefice, Benoît Souchet, Jérôme Braudeau, Sandro Alves, Françoise Piguet, Fanny Collaud, Giuseppe Ronzitti, Satoru Tada, Philippe Hantraye, Federico Mingozzi and 2 more

Open access · goldAbstract read
In one paragraph

Article in Molecular therapy. Methods & clinical development, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Exosomes in pathogenesis, diagnosis, and therapy of ischemic stroke.Frontiers in bioengineering and biotechnology · 2022
    Pooled it
  2. Overview of Delivery Methods for Gene Editing.Methods in molecular biology (Clifton, N.J.) · 2027
    Review
  3. Review
  4. Article
  5. Article
  6. Extracellular vesicles-associated AAVs for the treatment of Machado-Joseph disease.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Extracellular Vesicles for Disease Treatment.International journal of nanomedicine · 2025
    Review
  12. Review
  13. An Innovative Mitochondrial-targeted Gene Therapy for Cancer Treatment.bioRxiv : the preprint server for biology · 2024
    Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Cell-derived nanovesicle-mediated drug delivery to the brain: Principles and strategies for vesicle engineering.Molecular therapy : the journal of the American Society of Gene Therapy · 2023
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Nicola Salvatore OreficeINSERM UMR1169, Université Paris-Sud, Université Paris-Saclay, Orsay 94100, France.
Benoît SouchetINSERM UMR1169, Université Paris-Sud, Université Paris-Saclay, Orsay 94100, France.
Jérôme BraudeauINSERM UMR1169, Université Paris-Sud, Université Paris-Saclay, Orsay 94100, France.
Sandro AlvesINSERM UMR1169, Université Paris-Sud, Université Paris-Saclay, Orsay 94100, France.
Françoise PiguetINSERM UMR1169, Université Paris-Sud, Université Paris-Saclay, Orsay 94100, France.
Fanny CollaudINTEGRARE, Genethon, INSERM, Université Evry, Université Paris-Saclay, Evry 91002, France.
Giuseppe RonzittiINTEGRARE, Genethon, INSERM, Université Evry, Université Paris-Saclay, Evry 91002, France.
Satoru TadaINSERM UMR1169, Université Paris-Sud, Université Paris-Saclay, Orsay 94100, France.
Philippe HantrayeCEA, Fundamental Research Division (DRF), Institut of Biology Francois Jacob, Molecular Imaging Research Center (MIRCen), Fontenay-aux-Roses 92265, France.
Federico MingozziINTEGRARE, Genethon, INSERM, Université Evry, Université Paris-Saclay, Evry 91002, France.
Frédéric DucongéCEA, Fundamental Research Division (DRF), Institut of Biology Francois Jacob, Molecular Imaging Research Center (MIRCen), Fontenay-aux-Roses 92265, France.
Nathalie CartierINSERM UMR1169, Université Paris-Sud, Université Paris-Saclay, Orsay 94100, France.
Inserm · FRCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRDirection de la Recherche Fondamentale · FRCEA Paris-Saclay - Etablissement de Fontenay-aux-roses · FRInstitut des Maladies Neurodégénératives · FRUniversité Paris-Saclay · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exosomes represent a strategy for optimizing the adeno-associated virus (AAV) toward the development of novel therapeutic options for neurodegenerative disorders. However,

Indexed as

AAV6AAV9adeno-associated virusendomicroscopygene therapymicrovesiclevexosome

Identifiers

PMID31440523
PMCPMC6699252
OpenAlexW2955681916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.